It has also been suggested that both SHLP2 and humanin analog have chaperone-like activity by targeting the misfolding of islet amyloid polypeptide (IAPP), a critical pathogenic step in T2DM, and inhibit IAPP misfolding [126]. The gene discussed is MT-RNR2; the disease is type 2 diabetes mellitus.